Alembic Pharma Rises After USFDA Approval for Triamcinolone Acetonide Injectable Suspension
Mumbai, October 20 (Udaipur Kiran): Shares of Alembic Pharmaceuticals Limited gained over 1% in Monday’s trade after the company received final approval from the U.S. Food and Drug Administration (USFDA) for its Triamcinolone Acetonide Injectable Suspension USP. The stock was trading at Rs. 947.55, up Rs. 10.05 or 1.07% from its previous close of Rs. … Read more
